Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan‐cancer analysis-Reference-Cited by-同舟云学术

Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan‐cancer analysis

Published:2022-10-31 Issue:1 Volume:17 Page:150-172
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Wang Jing¹,Dai Mingkai²,Xing Xiangling²,Wang Xing³,Qin Xin⁴,Huang Tao¹³,Fang Zhiqing⁴,Fan Yidong⁴,Xu Dawei²^ORCID

Affiliation:

1. Department of Urologic Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei China

2. Division of Hematology, Department of Medicine, Bioclinicum and Center for Molecular Medicine Karolinska Institutet and Karolinska University Hospital Solna Stockholm Sweden

3. Department of Urology Surgery The First Affiliated Hospital of USTC, Wannan Medical college Wuhu China

4. Department of Urology Qilu Hospital of Shandong University Jinan China

Funder

Vetenskapsrådet

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13324

Reference65 articles.

1. Telomeres, telomerase, and aging: Origin of the theory